A study by Michigan Medicine researchers has investigated possible genetic factors for drug efficacy for children with ...

Infliximab is a chimeric monoclonal antibody ... at the Cedars-Sinai Inflammatory Bowel Disease Center, UCLA School of Medicine, Los Angeles, California, USA. Certolizumab pegol is the fourth ...

The success of infliximab paved the way for the introduction of other drugs with a similar mechanism of action. Three other TNF-blocking agents (etanercept, adalimumab and certolizumab pegol ...

"Both vedolizumab and infliximab are effective in biologic-naive ... No head-to-head trials exist and a prior comparison of the drugs' respective clinical trial data suggested similar rates ...

The Vilcek Foundation awarded the 2025 Prizes in Biomedical Science to Marianne Bronner, Elham Azizi, Guosong Hong, and Maayan Levy.